051915:KRXLG Chem, Ltd. Analysis
Data as of 2026-05-28 - not real-time
₩162,900.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
LG Chem’s price is currently trading below its 20‑day and 50‑day simple moving averages, indicating a short‑term downtrend despite a broader bullish bias in the longer‑term trend. The 14‑day RSI sits in the low‑40s, suggesting modest downside momentum but not yet oversold, while the MACD histogram remains firmly negative, reinforcing bearish technical pressure. Volatility is elevated, approaching 50% on a 30‑day basis, and beta exceeds 1.5, implying the stock is more sensitive to market swings than the average Korean equity. The market price is near the lower end of its 52‑week range and just above the identified support level, leaving limited downside cushion before testing that floor. Fundamentally, the company reports declining revenue, negative operating and profit margins, and a sizable net debt load that translates to a debt‑to‑equity ratio well above 70%. Free cash flow is deeply negative, raising questions about the sustainability of the modest 1.3% dividend yield. However, the discounted cash‑flow model places fair value roughly double the current price, flagging a potential value gap if the business can stabilize cash generation. Investors should weigh the technical weakness and high risk against the attractive valuation premium and dividend income, while remaining cautious of liquidity pressures as trading volume trends downward.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price perched just above key support with limited upside
- Bearish MACD and negative momentum indicators
- High volatility and beta increasing short‑term risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation suggests significant upside potential
- Modest dividend yield adds income appeal
- Potential recovery in chemicals demand could improve cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Heavy debt burden and negative free cash flow limit upside
- Sector cyclicality and regulatory exposure remain concerns
- Valuation still attractive if operational turnaround materializes
Key Metrics & Analysis
Financial Health
Revenue Growth-2.60%
Profit Margin-4.52%
ROE-5.93%
ROA-0.59%
Debt/Equity74.21
Op. Cash Flow₩6165.3B
Free Cash Flow₩-5942740516864
Technical Analysis
TrendBullish
RSI41.0
Support₩157,000.00
Resistance₩199,400.00
MA 20₩179,630.00
MA 50₩170,050.00
MA 200₩166,359.50
MACDBearish
VolumeDecreasing
Fear & Greed Index91.54
Valuation
Fair Value₩392,379.66
GradeUndervalued
TypeValue
Dividend Yield1.28%
Risk Assessment
Beta1.51
Volatility48.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.